Checkmate nets $20M to develop drug that boosts checkpoint inhibitor efficacy
Checkpoint Pharmaceuticals wants to advance a drug that boosts immune activity to make checkpoint inhibitors work better.
immune activity
Checkpoint Pharmaceuticals wants to advance a drug that boosts immune activity to make checkpoint inhibitors work better.